WELCOME

Dear Colleagues and Friends:

We are pleased to announce that the Symposium on Advanced Delivery Materials for Innovative Therapy (ADMIT 2026) will be held in October 16-18, 2026 at the Worldhotel Grand DushuLake, Suzhou, China.

ADMIT, formerly known as SIPCD, has been held biennially since its inception in 2010 and has evolved into a highly regarded international academic conference in the fields of biomedical materials, controlled release technology, and pharmaceutical sciences. The conference was renamed ADMIT to better align with the cutting-edge developments in biomedicine and drug delivery. ADMIT aims to provide a unique and open platform for scientific exchange—one that not only showcases the latest advances in drug delivery technologies and research findings but also encourages open and insightful discussion on critical challenges and potential solutions, thereby laying a foundation for future progress and clinical translation.

ADMIT has following highlights:

   400 Participants in one single session (without parallel sessions)

   30 Plenary lectures given by worldwide top scientists

   300 wall exhibition reports

   Vivid social program for networking

   Publication of a special issue in the J. Controlled Release

Suzhou is one of the most popular tourism cities in China. Being about one hour away by car or 30 mins by train from Shanghai, it can be easily reached from all over the world. The city stands out for its long history (over 2500 years), unique culture, beautiful traditional Chinese gardens, impressive canal systems, stone bridges, and silk products. Suzhou is also known as "Paradise on Earth" and "Oriental Venice".

We warmly invite you to actively participate in ADMIT 2026!

Zhiyuan Zhong
Soochow University, China / Associate Editor of JCR
Prof. Dr. Stefaan De Smedt
Ghent University, Belgium / Editor-in-Chief of JCR